Table 1.
Clinical Characteristics and Medication Use of Study Participants
| Group 1 (n = 30) | Group 2 (n = 14) | p | |
| Mean age (yrs) | 55.2 ± 10.0 | 51.8 ± 7.7 | NS |
| Male sex % (n) | 70%(21) | 64%(9) | NS |
| Diabetes Mellitus % (n) | 13%(4) | 14%(2) | NS |
| Hypertension % (n) | 30%(9) | 21%(3) | NS |
| Smoking % (n) | 60%(18) | 50%(7) | NS |
| TC (mg/dl) | 196.8 ± 31.7 | 195.1 ± 38.2 | NS |
| TG (mg/dl) | 148.7 ± 71.2 | 151.7 ± 64.0 | NS |
| HDL-C (mg/dl) | 46.7 ± 11.8 | 50.7 ± 13.0 | NS |
| LDL-C (mg/dl) | 125.1 ± 28.2 | 116.7 ± 34.2 | NS |
| hs-CRP (mg/L) | 4.78 ± 1.47 | 4.05 ± 1.53 | NS |
| MMP-1 (ng/ml) | 13.63 ± 7.73 | 12.15 ± 6.27 | NS |
| MMP-3 (ng/ml) | 20.23 ± 14.68 | 11.45 ± 6.55 | 0.039 |
| Baseline therapy | |||
| Aspirin | 73%(22) | 64%(9) | NS |
| Nitrate | 57%(17) | 64%(9) | NS |
| Statin | 17%(5) | 21%(3) | NS |
| Number of stenotic vessels | |||
| One vessel disease | 37%(11) | 36%(5) | NS |
| Two vessel disease | 50%(15) | 43%(6) | NS |
| Three vessel disease | 13%(4) | 21%(3) | NS |
| Reference vessel diameter (mm) | 2.95 ± 0.48 | - | - |
| Aneurysm vessel diameter (mm) | 4.78 ± 0.93 | - | - |
| Aneurysm/reference vessel ratio | 1.6 ± 0.1 | - | - |
| Aneurysm segment | |||
| Right coronary artery | 53%(16) | - | - |
| Left anterior descending artery | 27%(8) | - | - |
| Left Circumflex artery | 30%(9) | - | - |
Group 1:Patients with coronary aneurysm, Group 2:Patients without coronary aneurysm, TC:Total cholesterol, TG:Triglyceride, HDL-C:High-density lipoprotein cholesterol, LDL-C:Low-density lipoprotein cholesterol, hs-CRP:High sensitivity C- reactive protein, MMP-1:Matrix metalloproteinase-1, MMP-3:Matrix metalloproteinase-3, NS:Non-significant